Skip to main content
Erschienen in: Abdominal Radiology 6/2015

01.08.2015

Prediction of esophageal varices in cirrhotic patients with apparent diffusion coefficient of the spleen

verfasst von: Ahmed Abdel Khalek Abdel Razek, Samia Mohammed Ali Massoud, Mona Ramadan Abdel Azziz, Mahmoud Mostafa El-Bendary, Khaled Zalata, Enas Mohamed Motawea

Erschienen in: Abdominal Radiology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To predict esophageal varices in cirrhotic patients with apparent diffusion coefficient (ADC) of the spleen and to correlate the ADC with clinical and laboratory biomarkers of esophageal varices.

Materials and methods

This study was conducted upon 40 patients (28 male, 12 female; age ranged 19–45 years; mean age = 33 years) with biopsy-proven cirrhotic liver. Twenty age- and sex-matched healthy volunteers were included as a control group. Patients with varices (n = 15) and without varices (n = 25) and volunteers underwent echo-planar diffusion-weighted MR imaging of the abdomen with b factors of 0, 400, and 800 s/mm2. The ADC maps of the abdomen were reconstructed. The ADC values of the spleen were calculated and correlated with the Child score, platelet count, and prothrombin time.

Results

The mean ADC value of the spleen in cirrhotic patients (1.34 ± 0.05 × 10−3 mm2/s) was significantly different (P = 0.001) from that of volunteers (0.87 ± 0.04 × 10−3 mm2/s). The ADC of the spleen in cirrhotic patients with varices (1.49 ± 0.05 × 10−3 mm2/s) was significantly different (P = 0.001) from that of patients without varices (1.11 ± 0.06 × 10−3 mm2/s). The cut-off ADC value of the spleen used for prediction of cirrhosis and varices was 1.15 and 1.29 × 10−3 mm2/s with areas under the curve were 0.872 and 0.889, respectively. The ADC value of the spleen was correlated with the splenic volume (r = 0.862; P = 0.001), Child score (r = 0.742; P = 0.001), platelet count (r = –0.698; P = 0.01), and prothrombin time (r = 0.684; P = 0.01).

Conclusion

The ADC value of the spleen can predict esophageal varices in cirrhotic patients and is well correlated with the clinical and laboratory biomarkers of esophageal varices.
Literatur
1.
Zurück zum Zitat Zardi EM, Di Matteo FM, Pacella CM, Sanyal AJ (2014) Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review. Ann Med 46:8–17PubMedCrossRef Zardi EM, Di Matteo FM, Pacella CM, Sanyal AJ (2014) Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review. Ann Med 46:8–17PubMedCrossRef
2.
Zurück zum Zitat de Mattos ÂZ, de Mattos AA (2013) Noninvasive methods for esophageal varices prediction in cirrhotic patients: are we there yet? Gastroenterology 144:1151–1152PubMedCrossRef de Mattos ÂZ, de Mattos AA (2013) Noninvasive methods for esophageal varices prediction in cirrhotic patients: are we there yet? Gastroenterology 144:1151–1152PubMedCrossRef
4.
Zurück zum Zitat Eslam M, Ampuero J, Jover M, et al. (2013) Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables. Ann Hepatol 12:588–598PubMed Eslam M, Ampuero J, Jover M, et al. (2013) Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables. Ann Hepatol 12:588–598PubMed
5.
Zurück zum Zitat Mangone M, Moretti A, Alivernini F, et al. (2012) Platelet count/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis? Dig Liver Dis 44:504–507PubMedCrossRef Mangone M, Moretti A, Alivernini F, et al. (2012) Platelet count/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis? Dig Liver Dis 44:504–507PubMedCrossRef
6.
Zurück zum Zitat Ying L, Lin X, Xie Z, Hu Y, Shi K (2012) Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci 57:1672–1681PubMedCrossRef Ying L, Lin X, Xie Z, Hu Y, Shi K (2012) Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci 57:1672–1681PubMedCrossRef
7.
Zurück zum Zitat Berzigotti A, Reverter E, García-Criado A, et al. (2013) Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension. J Hepatol 59:717–722PubMedCrossRef Berzigotti A, Reverter E, García-Criado A, et al. (2013) Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension. J Hepatol 59:717–722PubMedCrossRef
8.
Zurück zum Zitat Zeng DB, Dai CZ, Lu SC, et al. (2013) Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension. World J Gastroenterol 19:1292–1298PubMedCentralPubMedCrossRef Zeng DB, Dai CZ, Lu SC, et al. (2013) Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension. World J Gastroenterol 19:1292–1298PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Baik SK (2010) Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review. Liver Int 30:1403–1413PubMedCrossRef Baik SK (2010) Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review. Liver Int 30:1403–1413PubMedCrossRef
10.
Zurück zum Zitat Berzigotti A, Seijo S, Arena U, et al. (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144:102–111PubMedCrossRef Berzigotti A, Seijo S, Arena U, et al. (2013) Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144:102–111PubMedCrossRef
11.
Zurück zum Zitat Hirooka M, Ochi H, Koizumi Y, et al. (2011) Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension. Radiology 261:960–968PubMedCrossRef Hirooka M, Ochi H, Koizumi Y, et al. (2011) Splenic elasticity measured with real-time tissue elastography is a marker of portal hypertension. Radiology 261:960–968PubMedCrossRef
12.
Zurück zum Zitat Bureau C, Metivier S, Peron JM, et al. (2008) Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 27:1261–1268PubMedCrossRef Bureau C, Metivier S, Peron JM, et al. (2008) Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 27:1261–1268PubMedCrossRef
13.
Zurück zum Zitat Talwalkar J, Yin M, Venkatesh S, et al. (2009) Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol 193:122–127PubMedCentralPubMedCrossRef Talwalkar J, Yin M, Venkatesh S, et al. (2009) Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol 193:122–127PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Vorobioff JD, Groszmann RJ (2013) Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage. Ann Hepatol 12:22–29PubMed Vorobioff JD, Groszmann RJ (2013) Hepatic venous pressure gradient measurement in pre-primary and primary prophylaxis of variceal hemorrhage. Ann Hepatol 12:22–29PubMed
15.
Zurück zum Zitat Razek AA, Elmongy A, Hazem M, Zakareyia S, Gabr W (2011) Idiopathic Parkinson disease effect of levodopa on apparent diffusion coefficient value of the brain. Acad Radiol 18:70–73PubMedCrossRef Razek AA, Elmongy A, Hazem M, Zakareyia S, Gabr W (2011) Idiopathic Parkinson disease effect of levodopa on apparent diffusion coefficient value of the brain. Acad Radiol 18:70–73PubMedCrossRef
16.
Zurück zum Zitat Abdel Razek AA, Sadek AG, Gaballa G (2010) Diffusion-weighed MR of the thyroid gland in Graves disease: assessment of disease activity and prediction of outcome. Acad Radiol 17:779–783PubMedCrossRef Abdel Razek AA, Sadek AG, Gaballa G (2010) Diffusion-weighed MR of the thyroid gland in Graves disease: assessment of disease activity and prediction of outcome. Acad Radiol 17:779–783PubMedCrossRef
17.
Zurück zum Zitat Razek AA, Abdalla A, Fathy A, Megahed A (2013) Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher’s disease type I and III. Skeletal Radiol 42:283–287PubMedCrossRef Razek AA, Abdalla A, Fathy A, Megahed A (2013) Apparent diffusion coefficient of the vertebral bone marrow in children with Gaucher’s disease type I and III. Skeletal Radiol 42:283–287PubMedCrossRef
18.
Zurück zum Zitat Culverwell A, Sheridan M, Guthrie J, Scarsbrook A (2013) Diffusion-weighted MRI of the liver: interpretative pearls and pitfalls. Clin Radiol 68:406–414PubMedCrossRef Culverwell A, Sheridan M, Guthrie J, Scarsbrook A (2013) Diffusion-weighted MRI of the liver: interpretative pearls and pitfalls. Clin Radiol 68:406–414PubMedCrossRef
19.
Zurück zum Zitat Sandrasegaran K, Akisik F, Lin C, et al. (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193:1556–1560PubMedCrossRef Sandrasegaran K, Akisik F, Lin C, et al. (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193:1556–1560PubMedCrossRef
20.
Zurück zum Zitat Razek AA, Abdalla A, Omran E, Fathy A, Zalata K (2011) Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol 78:129–134PubMedCrossRef Razek AA, Abdalla A, Omran E, Fathy A, Zalata K (2011) Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. Eur J Radiol 78:129–134PubMedCrossRef
21.
Zurück zum Zitat Tosun M, Inan N, Sarisoy H, et al. (2013) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82:203–207PubMedCrossRef Tosun M, Inan N, Sarisoy H, et al. (2013) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82:203–207PubMedCrossRef
22.
Zurück zum Zitat Barry B, Buch K, Soto J, et al. (2014) Quantifying liver fibrosis through the application of texture analysis to diffusion weighted imaging. Magn Reson Imaging 32:84–90PubMedCrossRef Barry B, Buch K, Soto J, et al. (2014) Quantifying liver fibrosis through the application of texture analysis to diffusion weighted imaging. Magn Reson Imaging 32:84–90PubMedCrossRef
23.
Zurück zum Zitat Razek AA, Khashaba M, Abdalla A, Bayomy M, Barakat T (2014) Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis. Radiol Med 119:903–909PubMedCrossRef Razek AA, Khashaba M, Abdalla A, Bayomy M, Barakat T (2014) Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis. Radiol Med 119:903–909PubMedCrossRef
24.
Zurück zum Zitat Cece H, Ercan A, Yıldız S, et al. (2013) The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis. Eur J Radiol 82:e307–e312PubMedCrossRef Cece H, Ercan A, Yıldız S, et al. (2013) The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis. Eur J Radiol 82:e307–e312PubMedCrossRef
25.
Zurück zum Zitat Klasen J, Lanzman RS, Wittsack HJ, et al. (2013) Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension. Magn Reson Imaging 31:1092–1096PubMedCrossRef Klasen J, Lanzman RS, Wittsack HJ, et al. (2013) Diffusion-weighted imaging (DWI) of the spleen in patients with liver cirrhosis and portal hypertension. Magn Reson Imaging 31:1092–1096PubMedCrossRef
26.
Zurück zum Zitat Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825–832PubMedCrossRef Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825–832PubMedCrossRef
27.
Zurück zum Zitat de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176PubMedCrossRef de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176PubMedCrossRef
28.
Zurück zum Zitat Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef
29.
Zurück zum Zitat Lee J, Kim KW, Lee H, et al. (2012) Semiautomated spleen volumetry with diffusion-weighted MR imaging. Magn Reson Med 68:305–310PubMedCrossRef Lee J, Kim KW, Lee H, et al. (2012) Semiautomated spleen volumetry with diffusion-weighted MR imaging. Magn Reson Med 68:305–310PubMedCrossRef
Metadaten
Titel
Prediction of esophageal varices in cirrhotic patients with apparent diffusion coefficient of the spleen
verfasst von
Ahmed Abdel Khalek Abdel Razek
Samia Mohammed Ali Massoud
Mona Ramadan Abdel Azziz
Mahmoud Mostafa El-Bendary
Khaled Zalata
Enas Mohamed Motawea
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0391-2

Weitere Artikel der Ausgabe 6/2015

Abdominal Radiology 6/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.